Search - tctmd.com

Displaying 81 - 100 of 6818

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

Presenter: Mohammed Ebrahim

October 27, 2025

Presentation TCT 2025

TCT 874: First-in-man Study of VitaFlow® III Controlled Bending Delivery System for Severe Aortic Stenosis: 30-Day Outcomes

Presenter: Yang Chen

October 27, 2025

Presentation TCT 2025

TCT 877: The PROVE registry: A prospective multi-center multi-national post-market registry of a short-frame supra-annular transcatheter aortic valve

Presenter: Oliver Dumpies

October 27, 2025

Presentation TCT 2025

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Presentation TCT 2025

TCT 876: Anatomical and Procedural Predictors of Early Adverse Outcomes After Transcatheter Aortic Valve Replacement using Navitor in Bicuspid Aortic Valve. Insight from The International Navitor Bicuspid Registry.

Presenter: Sami Alnasser

October 27, 2025

Presentation TCT 2025

TCT 767: Clinical Outcomes of GLP-1 Receptor Agonist Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

Presenter: Amer Hussein Muhyieddeen

October 27, 2025

Presentation TCT 2025

TCT 875: Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability

Presenter: SUSAN JAMES

October 27, 2025

Presentation TCT 2025

TCT 1402: Shear Consequences: A Case of Hemolytic Anemia From Paravalvular Leak Post-TAVR

Presenter: Benjamin Titus

October 27, 2025

Presentation TCT 2025

Procedural Planning for ViV TAVR

Presenter: Chad Alan Kliger

October 27, 2025

Presentation TCT 2025

TCT 1229: New-Onset Conduction Abnormalities Following Valve-in-Valve Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Judah Rajendran

October 27, 2025

Presentation TCT 2025

TCT 1225: Clinical Impact of Single- versus Multi-Access Technique for Valve-in-Valve Transcatheter Aortic Valve Replacement.

Presenter: Cesar Eduardo Soria Jimenez

October 27, 2025

Presentation TCT 2025

TCT 603: Performance of Aortic Valve Coefficient (AVC) in Relation with Calcium Score (CS) and Aortic Valve Area (AVA) in Patients Undergoing TAVR

Presenter: Rishi Sukhija

October 27, 2025

Presentation TCT 2025

TCT 1227: Redo-TAVR for Paravalvular Leak: Insight and Early Outcomes from Timing and Combinations

Presenter: Takayuki Onishi

October 27, 2025

Presentation TCT 2025

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

Presenter: Colin Jamieson

October 27, 2025

Presentation TCT 2025

TCT 1230: Clinical Outcomes of Intra-Annular Self-Expandable Transcatheter Aortic Valves for Valve-in-Valve procedure: Insights from the NAViV registry

Presenter: Luis Nombela-Franco

October 27, 2025

Presentation TCT 2025

TCT 724: Impact of Access Route on TAVR Outcomes in Patients with Moderate to Severe Obesity and Low and Intermediate Surgical Risk: An STS/ACC TVT Registry Analysis

Presenter: Mansi Maini

October 27, 2025

Presentation TCT 2025

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

Presenter: Anson Cheung

October 27, 2025

Presentation TCT 2025

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Presenter: Wenzhi Pan

October 27, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

TCT 766: Protamine At Reduced Dose For TAVR Anticoagulation Reversal

TCT 874: First-in-man Study of VitaFlow® III Controlled Bending Delivery System for Severe Aortic Stenosis: 30-Day Outcomes

TCT 877: The PROVE registry: A prospective multi-center multi-national post-market registry of a short-frame supra-annular transcatheter aortic valve

TCT 770: Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

TCT 876: Anatomical and Procedural Predictors of Early Adverse Outcomes After Transcatheter Aortic Valve Replacement using Navitor in Bicuspid Aortic Valve. Insight from The International Navitor Bicuspid Registry.

TCT 767: Clinical Outcomes of GLP-1 Receptor Agonist Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis

TCT 875: Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability

TCT 1402: Shear Consequences: A Case of Hemolytic Anemia From Paravalvular Leak Post-TAVR

Procedural Planning for ViV TAVR

TCT 1229: New-Onset Conduction Abnormalities Following Valve-in-Valve Transcatheter Aortic Valve Replacement (TAVR)

TCT 1225: Clinical Impact of Single- versus Multi-Access Technique for Valve-in-Valve Transcatheter Aortic Valve Replacement.

TCT 603: Performance of Aortic Valve Coefficient (AVC) in Relation with Calcium Score (CS) and Aortic Valve Area (AVA) in Patients Undergoing TAVR

TCT 1227: Redo-TAVR for Paravalvular Leak: Insight and Early Outcomes from Timing and Combinations

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

TCT 1230: Clinical Outcomes of Intra-Annular Self-Expandable Transcatheter Aortic Valves for Valve-in-Valve procedure: Insights from the NAViV registry

TCT 724: Impact of Access Route on TAVR Outcomes in Patients with Moderate to Severe Obesity and Low and Intermediate Surgical Risk: An STS/ACC TVT Registry Analysis

Transcatheter Aortic Valve Replacement with Ken-Valve™ in Aortic Regurgitation (Jenscare Scientific): 1- Year Outcomes and Large Annulus Subgroup Analysis

The Hanchor Valve for the Treatment of Patients with Severe Aortic Regurgitation (Hanling Medical): 1-Year Results of the Multi-Center HAVE AR Trial

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content